{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T02:49:40Z","timestamp":1767926980959,"version":"3.49.0"},"reference-count":72,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T00:00:00Z","timestamp":1670284800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Monoamine oxidases are mitochondrial enzymes that catalyze the oxidative deamination of biogenic amines (adrenaline, noradrenaline, serotonin, and dopamine), causing their inactivation and subsequently playing a fundamental role in the homeostasis of various neurotransmitters. As the regulation of these effects was deemed important in clinical practice, numerous modulators of these enzymes were tested for various clinical effects. The purpose of this paper is to present a few historical landmarks regarding monoaminoxidase inhibitors and their usefulness as psychopharmacological agents. We will be focusing on banisterine, iproniazid, selegiline, rasagiline, tranylcypromine, moclobemide, and their role in the history of psychopharmacology. An almost unknown fact is that harmine, an MAO-A alkaloid, was used as early as the latter half of the 1920s in Bucharest, to reduce catatonic symptoms in schizophrenia, thus ushering the dawn of psychopharmacology era which started with chlorpromazine in the 1950s.<\/jats:p>","DOI":"10.3389\/fphar.2022.1053534","type":"journal-article","created":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T08:27:04Z","timestamp":1670315224000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Altered states, alkaloids, and catatonia: Monoaminoxidase inhibitors and their role in the history of psychopharmacology"],"prefix":"10.3389","volume":"13","author":[{"given":"Octavian","family":"Buda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sorin","family":"Hostiuc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ovidiu","family":"Popa-Velea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steluta","family":"Boroghina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,12,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"95","DOI":"10.4103\/0019-5545.94660","article-title":"Paul Eugen Bleuler and the origin of the term schizophrenia (schizopreniegruppe)","volume":"54","author":"Ashok","year":"2012","journal-title":"Indian J. Psychiatry"},{"key":"B2","article-title":"Act regarding the medical organization of the state [Legea privind organizarea medical\u0103 a statului]","year":""},{"key":"B3","first-page":"9258","article-title":"Act regarding the fight against venereal diseases [Regulamentul Nr.24 referitor la lupta contra bolilor venerice]","year":""},{"key":"B4","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1177\/0091270007304779","article-title":"Pharmacokinetics and absolute bioavailability of selegiline following treatment of healthy subjects with the selegiline transdermal system (6 mg\/24 h). A comparison with oral selegiline capsules","volume":"47","author":"Azzaro","year":"2007","journal-title":"J. Clin. Pharmacol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1001\/archpsyc.1974.01760160093019","article-title":"Human platelet monoamine oxidase changes during the menstrual cycle","volume":"31","author":"Belmaker","year":"1974","journal-title":"Arch. Gen. Psychiatry"},{"key":"B6","first-page":"265","article-title":"\u00dcber ein neues, auf das extrapyramidal-motorische System wirkendes Alkaloid (Banisterin)","volume":"1","author":"Beringer","year":"1928","journal-title":"Nervenarzt"},{"key":"B7","first-page":"548","article-title":"Zur banisterin-und harminfrage","volume":"2","author":"Beringer","year":"1929","journal-title":"Nervenarzt"},{"key":"B83","first-page":"436","article-title":"Die Prognose der Dementia praecox (Schizophreniegruppe)","volume":"65","author":"Bleuler","year":"1908","journal-title":"Allgemeine Zeitschrift f\u00fcr Psychiatrie und psychisch-gerichtliche Medizin"},{"key":"B8","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1007\/bf01562834","article-title":"Psychological performance tests as prognostic agents for the efficacy of insulin therapy in schizophrenia","volume":"12","author":"Bolles","year":"1938","journal-title":"Psychiatr. Q."},{"key":"B9","first-page":"55","article-title":"Variation de la Chronaxie dans les \u00e9tats cataleptoides provoqu\u00e9s chez le chat par injection de bulbocapnine","volume":"99","author":"Bourguignon","year":"1928","journal-title":"CR Soc. Biol. Paris"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1001\/jama.1937.02780480065025","article-title":"Coma in insulin-hypoglycemic therapy of schizophrenia","volume":"109","author":"Brody","year":"1937","journal-title":"J. Am. Med. Assoc."},{"key":"B11","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1007\/BF00690936","article-title":"The negative symptoms of schizophrenia and the monoamine oxidase inhibitors","volume":"91","author":"Bucci","year":"1987","journal-title":"Psychopharmacology"},{"key":"B12","doi-asserted-by":"publisher","first-page":"79","DOI":"10.4323\/rjlm.2013.79","article-title":"The institutionalization of asylum and forensic psychiatry in Bucharest, 19th century. A historical outline","volume":"21","author":"Buda","year":"2013","journal-title":"Rom. J. Leg. Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1177\/0957154X09355726","article-title":"The face of madness in Romania: The origin of psychiatric photography in eastern europe","volume":"21","author":"Buda","year":"2010","journal-title":"Hist. Psychiatry"},{"key":"B14","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/S0161-813X(03)00107-4","article-title":"Tobacco leaf, smoke and smoking, MAO inhibitors, Parkinson\u2019s disease and neuroprotection; are there links?","volume":"25","author":"Castagnoli","year":"2004","journal-title":"NeuroToxicology"},{"key":"B15","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/978-3-7091-9113-2_33","article-title":"Monoamine oxidase and oxidative stress at dopaminergic synapses","volume-title":"Amine oxidases and their impact on neurobiology","author":"Cohen","year":"1990"},{"key":"B16","article-title":"The medical year 1943. Annual report","author":"Cosmulescu","year":"1944","journal-title":"Rom\u00e2nia Medical\u0103"},{"key":"B17","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1042\/bj0270727","article-title":"The chemotherapy of derivatives of harmine and harmaline. I","volume":"27","author":"Coulthard","year":"1933","journal-title":"Biochem. J."},{"key":"B18","doi-asserted-by":"publisher","first-page":"80","DOI":"10.4103\/psychiatry.IndianJPsychiatry_54_19","article-title":"Prediction of schizophrenia using MAOA-uVNTR polymorphism: A case-control study","volume":"62","author":"Culej","year":"2020","journal-title":"Indian J. Psychiatry"},{"key":"B19","first-page":"310","article-title":"Action de la bulbocapnine sur la chronaxie chez le chat et chez l\u2019homme normal","author":"De Jong","year":"1928","journal-title":"Rev. Neurol."},{"key":"B20","first-page":"267","article-title":"Therapeutic method derived from hiberno-therapy in excitation and agitation states","volume":"110","author":"Delay","year":"1952","journal-title":"Ann. Med. Psychol."},{"key":"B21","first-page":"298","article-title":"Evaluation of results from leukotomy in schizophrenia","volume":"11","author":"Feld","year":"1950","journal-title":"Dis. Nerv. Syst."},{"key":"B22","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1021\/jo50014a014","article-title":"Synthetic tuberculostats. VII. Monoalkyl derivatives of isonicotinyhydrazine","volume":"18","author":"Fox","year":"1953","journal-title":"J. Org. Chem."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1176\/appi.ajp.2008.08050714","article-title":"Paul Eugen Bleuler and the birth of schizophrenia (1908)","volume":"165","author":"Fusar-Poli","year":"2008","journal-title":"Am. J. Psychiatry"},{"key":"B24","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1515\/BMC.2011.030","article-title":"Structures and mechanism of the monoamine oxidase family","volume":"2","author":"Gaweska","year":"2011","journal-title":"Biomol. Concepts"},{"key":"B25","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/sj.jcbfm.9600197","article-title":"Positron emission tomography quantification of [11C]-harmine binding to monoamine oxidase-A in the human brain","volume":"26","author":"Ginovart","year":"2005","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"B26","doi-asserted-by":"publisher","first-page":"73","DOI":"10.4323\/rjlm.2011.73","article-title":"Legal highs\" in Romania: Historical and present facts","volume":"19","author":"Gorun","year":"2011","journal-title":"Rom. J. Leg. Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"217","DOI":"10.4323\/rjlm.2008.217","article-title":"Retrospective study of forensic medicine's management of drug related deaths in Romania: 2001-2007","volume":"16","author":"Gorun","year":"2008","journal-title":"Rom. J. Leg. Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1111\/j.1471-4159.1990.tb03121.x","article-title":"Tissue distribution of human monoamine oxidase A and B mRNA","volume":"55","author":"Grimsby","year":"1990","journal-title":"J. Neurochem."},{"key":"B29","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1017\/s0080456800018779","article-title":"IV.\u2014the pharmacological action of harmine","volume":"48","author":"Gunn","year":"1912","journal-title":"Trans. R. Soc. Edinb. Earth. Sci."},{"key":"B30","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1007\/bf01566801","article-title":"Rorschach interpretation of the personality structure of schizophrenics who benefit from insulin therapy","volume":"14","author":"Halpern","year":"1940","journal-title":"Psychiatr. Q."},{"key":"B31","doi-asserted-by":"crossref","first-page":"80","DOI":"10.2307\/j.ctv2k4fwvb.6","article-title":"Explorations in a new world","volume-title":"The creation of psychopharmacology","author":"Healy","year":"2004"},{"key":"B32","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1039\/CT9120101775","article-title":"Harmine and harmaline. CXC. Part I","volume":"101","author":"Henrya Perkin","year":"1912","journal-title":"J. Chem. Soc. Trans."},{"key":"B33","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/s0140-6736(01)04243-x","article-title":"Worster-drought C","volume":"214","author":"Hill","year":"1929","journal-title":"Lancet"},{"key":"B34","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.schres.2014.08.006","article-title":"Harmine for catatonic schizophrenia. A forgotten experiment","volume":"159","author":"Hostiuc","year":"2014","journal-title":"Schizophr. Res."},{"key":"B35","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/s0924-9338(15)31359-6","article-title":"Petre Tomescu and his early studies in catatonic schizophrenia","volume":"30","author":"Hostiuc","year":"2015","journal-title":"Eur. Psychiatry"},{"key":"B36","doi-asserted-by":"publisher","first-page":"74","DOI":"10.3389\/fnana.2016.00074","article-title":"Shake the disease. Georges Marinesco, Paul Blocq and the pathogenesis of parkinsonism","volume":"10","author":"Hostiuc","year":"2016","journal-title":"Front. Neuroanat."},{"key":"B37","first-page":"401","article-title":"Favorable results in dementia praecox with the use of castor oil and forced feeding","volume":"56","author":"Ingham","year":"1930","journal-title":"Tr. Am. Neurol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1006\/abbi.1996.9771","article-title":"Inhibition of monoamine oxidase A by beta-carboline derivatives","volume":"337","author":"Kim","year":"1997","journal-title":"Arch. Biochem. Biophys.January 1"},{"key":"B39","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/bf02869781","article-title":"\u00dcber die therapeutische Anwendung der \u201cDauernarkose\u201d mittels Somnifens bei Schizophrenen","volume":"74","author":"Kl\u00e4si","year":"1922","journal-title":"Z. F. D. G. Neur. U. Psych."},{"key":"B40","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1007\/bf02876753","article-title":"Tierbluteinspritzungen bei Psychosen","volume":"76","author":"Klebelsberg","year":"1922","journal-title":"Z. F. D. G. Neur. U. Psych."},{"key":"B41","volume-title":"Psychiatrie","author":"Kraepelin","year":"1896"},{"key":"B42","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1177\/070674379704200205","article-title":"The history of the psychopharmacology of schizophrenia","volume":"42","author":"Lehmann","year":"1997","journal-title":"Can. J. Psychiatry."},{"key":"B43","first-page":"419","article-title":"Ergebnisse von Banisterinversuchen an kranken","volume":"55","author":"Lewin","year":"1929","journal-title":"Dtsch. Med. Wochenschr."},{"key":"B44","first-page":"469","article-title":"Sur une substance enivrante, la banisterine, extraite de Banisteria caapi","volume":"186","author":"Lewin","year":"1928","journal-title":"Comptes Rendus Acad. Sci."},{"key":"B45","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/0165-1781(84)90010-6","article-title":"Negative symptoms and platelet monoamine oxidase activity in male schizophrenic patients","volume":"12","author":"Lewine","year":"1984","journal-title":"Psychiatry Res."},{"key":"B46","doi-asserted-by":"publisher","first-page":"219","DOI":"10.2165\/00002018-199614040-00002","article-title":"Monoamine oxidase inhibitors - an update on drug interactions","volume":"14","author":"Livingston","year":"1996","journal-title":"Drug Saf."},{"key":"B47","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/0920-9964(92)90019-2","article-title":"Platelet monoamine oxidase in schizophrenia: A meta-analysis","volume":"7","author":"Marcolin","year":"1992","journal-title":"Schizophr. Res."},{"key":"B48","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1192\/bjp.97.406.132","article-title":"Insulin coma therapy of schizophrenia: Some critical remarks on Dr. Sakel's report","volume":"97","author":"Mayer-Gross","year":"1951","journal-title":"J. Ment. Sci."},{"key":"B49","doi-asserted-by":"publisher","first-page":"199","DOI":"10.4103\/0973-7847.120524","article-title":"Pharmacological and therapeutic effects of Peganum harmala and its main alkaloids","volume":"7","author":"Moloudizargari","year":"2013","journal-title":"Pharmacogn. Rev."},{"key":"B50","first-page":"2","article-title":"Digging out the crimes of the communism [Dezgrop\u00e2nd crimele comunismului]","volume":"414","author":"Muraru","year":"2013","journal-title":"Obsevatorul Cult."},{"key":"B51","doi-asserted-by":"publisher","first-page":"100607","DOI":"10.1016\/j.rechem.2022.100607","article-title":"The inhibition of monoamine oxidase by harmine derivatives","volume":"4","author":"Myburg","year":"2022","journal-title":"Results Chem."},{"key":"B52","doi-asserted-by":"publisher","first-page":"676239","DOI":"10.3389\/fphar.2021.676239","article-title":"Monoamine oxidase inhibitors: A review of their anti-inflammatory therapeutic potential and mechanisms of action","volume":"12","author":"Ostadkarampour","year":"2021","journal-title":"Front. Pharmacol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0165-1781(92)90082-e","article-title":"L-Deprenyl in treating negative symptoms of schizophrenia","volume":"42","author":"Perenyi","year":"1992","journal-title":"Psychiatry Res."},{"key":"B54","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1176\/ajp.104.8.513","article-title":"Prefrontal lobectomy (excision of the anterior areas of the cerebrum. A new form of psychosurgery","volume":"104","author":"Peyton","year":"1948","journal-title":"Am. J. Psychiatry"},{"key":"B55","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/BF02041242","article-title":"The discovery of antidepressants: A winding path","volume":"47","author":"Pletscher","year":"1991","journal-title":"Experientia"},{"key":"B56","doi-asserted-by":"publisher","first-page":"3347","DOI":"10.1002\/prot.24690","article-title":"Empirical valence bond simulations of the hydride transfer step in the monoamine oxidase B catalyzed metabolism of dopamine","volume":"82","author":"Repic","year":"2014","journal-title":"Proteins"},{"key":"B57","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1055\/s-0028-1126437","article-title":"Versuche mit Harmin bei Metenzephalitikern","volume":"55","author":"Rustige","year":"1929","journal-title":"Dtsch. Med. Wochenschr."},{"key":"B84","volume-title":"Awakenings","author":"Sacks","year":"1973"},{"key":"B58","first-page":"324","article-title":"Platelet MAO activity in subgroups of schizophrenia","volume":"32","author":"Sharma","year":"1990","journal-title":"Indian J. Psychiatry"},{"key":"B59","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1097\/00004850-199905002-00009","article-title":"The effect of augmentation with moclobemide on symptoms of schizophrenia","volume":"14","author":"Silver","year":"1999","journal-title":"Int. Clin. Psychopharmacol."},{"key":"B60","first-page":"519","article-title":"The use of the isopropyl derivative of isonicotinylhydrazine (marsilid) in the treatment of mental disease; a preliminary report","volume":"4","author":"Smith","year":"1953","journal-title":"Am. Pract. Dig. Treat."},{"key":"B61","doi-asserted-by":"publisher","first-page":"6151","DOI":"10.3390\/ijms21176151","article-title":"Hydride abstraction as the rate-limiting step of the irreversible inhibition of monoamine oxidase B by rasagiline and selegiline: A computational empirical valence bond study","volume":"21","author":"Tandaric","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B67","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/bf02679164","article-title":"Experimentelle Untersuchungen \u00fcber die Konzentration und Ausscheidung des Alkohols im Blut und in der Cerebrospinalfl\u00fcssigkeit","volume":"99","author":"Tomescu","year":"1936","journal-title":"Z. Ges. Exp. Med."},{"key":"B73","first-page":"209","article-title":"Experimental researches regarding the therapeutic action of Harmine on the catatonic syndrome [Cercet\u0103ri experimentale referitoare la ac\u0163iunea terapeutic\u0103 a Harminei asupra sindromului catatonic]","author":"Tomescu","year":"1930","journal-title":"Rev. Spitalul Bucharest"},{"key":"B76","first-page":"341345","article-title":"On the concentration and excretion of alcohol of blood and cerebro-spinal fluid of normal, pellagrous, chronic and acute alcoholic men and of experimentally alcoholic animals (in levy M: Zeitschr. Ges. Exp. Med","author":"Tomescu","year":"1937","journal-title":"Br. J. Psychiatry"},{"key":"B77","doi-asserted-by":"publisher","first-page":"221","DOI":"10.5708\/ejmh.7.2012.2.4","article-title":"The history of psychotherapy in Rumania during the socialist dictatorship of Nicolae Ceausescu","volume":"7","author":"Tudose","year":"2012","journal-title":"Eur. J. Ment. Health"},{"key":"B78","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1017\/s002572730000332x","article-title":"\u201cTo End the Degeneration of a Nation\u201d: Debates on eugenic sterilization in inter-war Romania","volume":"53","author":"Turda","year":"2009","journal-title":"Med. Hist."},{"key":"B79","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1111\/j.1748-1716.1986.tb07796.x","article-title":"Reduced platelet MAO activity during pregnancy","volume":"126","author":"Wahlund","year":"1986","journal-title":"Acta Physiol. Scand."},{"key":"B80","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1093\/schbul\/2.1.77","article-title":"Low platelet monoamine oxidase activity and schizophrenia","volume":"2","author":"Wyatt","year":"1976","journal-title":"Schizophr. Bull."},{"key":"B81","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/s0035-9203(24)90664-x","article-title":"Observations on malaria made during treatment of general paralysis","volume":"18","author":"Yorke","year":"1924","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"B82","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/nrn1883","article-title":"The therapeutic potential of monoamine oxidase inhibitors","volume":"7","author":"Youdim","year":"2006","journal-title":"Nat. Rev. Neurosci."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.1053534\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T08:27:14Z","timestamp":1670315234000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.1053534\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,6]]},"references-count":72,"alternative-id":["10.3389\/fphar.2022.1053534"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2022.1053534","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,6]]},"article-number":"1053534"}}